Skip to main content
Signal8
Last Andrew J. profile photo

Andrew J. Last

CIK: 0001485088

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (7.7%)

Position reduction

Option Exercises (M)5 (38.5%)

Derivative conversions

Awards (A)2 (15.4%)

Compensation grants

Other (G, F, J, C, D, …)5 (38.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Insight Molecular Diagnostics Inc. logo
IMDX

Insight Molecular Diagnostics Inc.

Director
BIO-RAD LABORATORIES, INC. logo
BIO BIOB

BIO-RAD LABORATORIES, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Jul 1, 2026
    Tax Payment(F)
    Direct
    7.7K shares at avg. $5.69$44K
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Jun 11, 2026
    Award(A)
    Direct
    26.9K shares-
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Jul 1, 2025
    Award(A)
    Direct
    35K shares-
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 6, 2024
    Exercise(M)
    Direct
    3K shares at avg. $299.24$898K
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 6, 2024
    Sale(S)
    Direct
    3K shares at avg. $329.94$990K
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 2, 2024
    Tax Payment(F)
    Direct
    458 shares at avg. $337.32$154K
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 2, 2024
    Exercise(M)
    Direct
    903 shares-
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 1, 2024
    Exercise(M)
    Direct
    867 shares-
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 1, 2024
    Tax Payment(F)
    Direct
    440 shares at avg. $337.32$148K
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 1, 2024
    Exercise(M)
    Direct
    633 shares-
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 1, 2024
    Tax Payment(F)
    Direct
    321 shares at avg. $337.32$108K
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 1, 2024
    Exercise(M)
    Direct
    1.3K shares-
  • BIO-RAD LABORATORIES, INC. logo
    BIO BIOB

    BIO-RAD LABORATORIES, INC.

    Sep 1, 2024
    Tax Payment(F)
    Direct
    635 shares at avg. $337.32$214K

1-13 of 13

About Last Andrew J.

Last Andrew J. (SEC CIK 0001485088) files insider reports with the SEC as Director of Insight Molecular Diagnostics Inc. (IMDX) and EVP, Chief Operating Officer of BIO-RAD LABORATORIES, INC. (BIO BIOB).

Signal8 holds 5 ownership filings by Last Andrew J., all Form 4s, filed between Sep 4, 2024 and Jul 6, 2026. Those filings report 13 transactions, from Sep 1, 2024 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Last Andrew J.'s filings is in NASHVILLE, TN.

Recent filings by Last Andrew J.

  • Jul 1, 2026: Tax withholding of IMDX shares (Form 4, code F).
  • Jun 11, 2026: Grant or award of IMDX shares (Form 4, code A).
  • Jul 1, 2025: Grant or award of IMDX shares (Form 4, code A).
  • Sep 6, 2024: Option exercise of BIO BIOB shares (Form 4, code M).
  • Sep 6, 2024: Open-market sale of BIO BIOB shares (Form 4, code S).

Other insiders filing for Insight Molecular Diagnostics Inc. (IMDX)

How to read Form 4 transaction codes